Literature DB >> 22542216

The mucosal immune system of the respiratory tract.

Shintaro Sato1, Hiroshi Kiyono.   

Abstract

Most viruses use host mucosal surfaces as their initial portals of infection. The respiratory tract has the body's second-largest mucosal surface area after the digestive tract. An understanding of the unique nature of the mucosal immune system of respiratory organs is therefore extremely important for the development of new-generation vaccines and novel methods of preventing and treating respiratory infectious diseases, including viral infections.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22542216     DOI: 10.1016/j.coviro.2012.03.009

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  24 in total

1.  Psychological distress and salivary secretory immunity.

Authors:  C G Engeland; F N Hugo; J B Hilgert; G G Nascimento; R Junges; H-J Lim; P T Marucha; J A Bosch
Journal:  Brain Behav Immun       Date:  2015-08-28       Impact factor: 7.217

Review 2.  Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.

Authors:  Mevyn Nizard; Mariana O Diniz; Helene Roussel; Thi Tran; Luis Cs Ferreira; Cecile Badoual; Eric Tartour
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 3.  Next generation protein based Streptococcus pneumoniae vaccines.

Authors:  Michael E Pichichero; M Nadeem Khan; Qingfu Xu
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

Review 4.  Non-Reflex Defense Mechanisms of Upper Airway Mucosa: Possible Clinical Application.

Authors:  H Pedan; V Janosova; A Hajtman; V Calkovsky
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

Review 5.  Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure.

Authors:  Tao Zhang; Kewei Sun; Ya Wang; Lei Huang; Ren Lang; Wei Jiang
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-02       Impact factor: 2.586

6.  Human pharyngeal microbiome may play a protective role in respiratory tract infections.

Authors:  Zhancheng Gao; Yu Kang; Jun Yu; Lufeng Ren
Journal:  Genomics Proteomics Bioinformatics       Date:  2014-06-18       Impact factor: 7.691

7.  Higher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children.

Authors:  Q Xu; J R Casey; M E Pichichero
Journal:  Mucosal Immunol       Date:  2015-02-04       Impact factor: 7.313

8.  Characteristics of nasal-associated lymphoid tissue (NALT) and nasal absorption capacity in chicken.

Authors:  Haihong Kang; Mengfei Yan; Qinghua Yu; Qian Yang
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

9.  Development of oligomannose-coated liposome-based nasal vaccine against human parainfluenza virus type 3.

Authors:  Kyosuke Senchi; Satoko Matsunaga; Hideki Hasegawa; Hirokazu Kimura; Akihide Ryo
Journal:  Front Microbiol       Date:  2013-11-26       Impact factor: 5.640

10.  Clinical profile of recurrent community-acquired pneumonia in children.

Authors:  Francesca Patria; Benedetta Longhi; Claudia Tagliabue; Rossana Tenconi; Patrizia Ballista; Giuseppe Ricciardi; Carlotta Galeone; Nicola Principi; Susanna Esposito
Journal:  BMC Pulm Med       Date:  2013-10-10       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.